Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a placebo-controlled trial of SAR445399 in adults with non-cystic fibrosis bronchiectasis
MOH_2026-04-29_015792Phase 2Not yet recruiting
- Sponsor
- Sanofi
- Start
- Apr 2026
- Modality
- Nanobodies (VHH) → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchiectasis comparing SAR445399 with Placebo (2 arms). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
SAR445399
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on MOH_2026-04-29_015792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2026-04-29_015792.